4.4 Review

Radioiodine Remnant Ablation for Differentiated Thyroid Cancer A Systematic Review and Meta-analysis

期刊

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY
卷 147, 期 6, 页码 544-552

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jamaoto.2021.0288

关键词

-

向作者/读者索取更多资源

The study compared the effects of low- and high-activity RAI on long-term cure rates in low- and intermediate-risk thyroid cancer, showing no significant difference in successful ablation and recurrence rates between the two. Therefore, low-activity RAI may be preferred in low- and intermediate-risk DTC due to its similar efficacy but reduced morbidity.
IMPORTANCE Postoperative radioactive iodine (RAI) remnant ablation for differentiated thyroid cancer (DTC) facilitates the early detection of recurrence and represents an adjuvant therapy that targets persistent microscopic disease. The optimal activity of RAI in low- and intermediate-risk DTC remains controversial. OBJECTIVE To evaluate the long-term cure rate of different RAI activities in low- and intermediate-risk DTC. Secondary outcomes included successful remnant ablation, adverse effects, and hospital length of stay. DATA SOURCE A systematic search of the databases PubMed, Cochrane Collaboration, Embase, Scopus, andWeb of Science was performed to identify randomized clinical trials (RCTs) and observational studies that compared long-term outcomes (>12 months) for American Thyroid Association-classified low- and intermediate-risk DTC based on receipt of either low-activity or high-activity RAI postoperatively. STUDY SELECTION All RCTs or observational studies evaluating patients with low- and intermediate-risk DTC who were treated initially with total/near-total thyroidectomy, followed by remnant RAI ablation with either low or high activities. Eligible studies had to present odds ratio, relative risk (RR), or hazard ratio estimates (with 95% CIs), standard errors, or the number of events necessary to calculate these for the outcome of interest rate. DATA EXTRACTION Two investigators reviewed the literature in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Dichotomous variables were pooled as risk ratios and continuous data as weighted-mean differences. Quality assessment of the included studies was performed using the Newcastle-Ottawa and Jadad scales. MAIN OUTCOMES AND MEASURES Disease recurrencewas the primary outcome. Secondary outcomes included successful ablation, adverse effects, and length of stay. RESULTS Ten studies that included 3821 patients met inclusion criteria, including 6 RCTs and 4 observational studies. There was no difference in long-term cure recurrence rates (RR, 0.88; 95% CI, 0.62-1.27, P =.50) or successful remnant ablation (RR, 0.95; 95% CI, 0.87-1.03; P =.20) between low-activity and high-activity RAI. CONCLUSIONS AND RELEVANCE In this systematic review and meta-analysis, low-activity RAI was comparable with high-activity RAI regarding successful ablation and recurrence rates. This suggests that low-activity RAI is preferable to high-activity in low- and intermediate-risk DTC because of its similar efficacy but reduced morbidity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据